Related references
Note: Only part of the references are listed.Therapeutic targets and recent advances in protein immunotoxins
J. Madhumathi et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Reduction of activated macrophages after ischaemiareperfusion injury diminishes oxidative stress and ameliorates renal damage
Ngwi G. Fet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
Wenhai Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis
Carmen A. Ambarus et al.
ARTHRITIS RESEARCH & THERAPY (2012)
An Aggressive Medical Approach for Inflammatory Bowel Disease: Clinical Challenges and Therapeutic Profiles in a Retrospective Hospital-based Series
Giovanni C. Actis et al.
CURRENT CLINICAL PHARMACOLOGY (2012)
Heme Induces Heme Oxygenase 1 via Nrf2 Role in the Homeostatic Macrophage Response to Intraplaque Hemorrhage
Joseph J. Boyle et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Macrophages and liposomes in inflammatory disease: Friends or foes?
B. J. Crielaard et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice
Anca Sindrilaru et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cytosolic DNA sensors regulating type I interferon induction
Sinead E. Keating et al.
TRENDS IN IMMUNOLOGY (2011)
Recombinant, ETA'-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice
T. Ribbert et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2
Alexandra Kadl et al.
CIRCULATION RESEARCH (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Investigation of a plasmid containing a novel immunotoxin VEGF165-PE38 gene for antiangiogenic therapy in a malignant glioma model
Chang-chen Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells
Xin-Xin Zhou et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
Christian A. Gleissner et al.
JOURNAL OF IMMUNOLOGY (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Roles of Glu 349 and Asp 352 in membrane insertion and translocation by diphtheria toxin
Poonam Kaul et al.
PROTEIN SCIENCE (2010)
Suppression of PLCβ2 by Endotoxin Plays a Role in the Adenosine A2A Receptor-Mediated Switch of Macrophages from an Inflammatory to an Angiogenic Phenotype
Stan Grinberg et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Coronary Intraplaque Hemorrhage Evokes a Novel Atheroprotective Macrophage Phenotype
Joseph J. Boyle et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Absence of a Classically Activated Macrophage Cytokine Signature in Peripheral Spondylarthritis, Including Psoriatic Arthritis
Bernard Vandooren et al.
ARTHRITIS AND RHEUMATISM (2009)
Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
Mrudula Mathew et al.
CANCER SCIENCE (2009)
Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
B. Cate et al.
CURRENT DRUG TARGETS (2009)
Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies
Robert J. Kreitman
CURRENT PHARMACEUTICAL DESIGN (2009)
Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy
Mehmet Kemal Tur et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Improved Immunotoxins with Novel Functional Elements
C. Hetzel et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Targeted Restoration of Down-regulated DAPK2 Tumor Suppressor Activity Induces Apoptosis in Hodgkin Lymphoma Cells
Mehmet Kemal Tur et al.
JOURNAL OF IMMUNOTHERAPY (2009)
A neutralizing antibody to the A chain of Abrin inhibits Abrin toxicity both in vitro and in vivo
Kalpana Surendranath et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Macrophage activation and polarization
Fernando Oneissi Martinez et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Cytokine signaling modules in inflammatory responses
John J. O'Shea et al.
IMMUNITY (2008)
Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring
Ryoichi Mori et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Small cleavable adapters enhance the specific cytotoxicity of a humanized immunotoxin directed against CD64-positive cells
Christian Hetzel et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Granzyme B-H22(scFv), a human immunotoxin targeting CD64 in acute myeloid leukemia of monocytic subtypes
Bettina Stahnke et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair
Brian M. Stramer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing
Kazuichi Maruyama et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Inflammation in wound repair: Molecular and cellular mechanisms
Sabine A. Eming et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Macrophages use different internalization mechanisms to clear apoptotic and necrotic cells
D. V. Krysko et al.
CELL DEATH AND DIFFERENTIATION (2006)
Biochemical and functional characterization of three activated macrophage populations
Justin P. Edwards et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Clearance of apoptotic and necrotic cells and its immunological consequences
Dmitri V. Krysko et al.
APOPTOSIS (2006)
Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES
Y. Jia et al.
GENE THERAPY (2006)
Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin
Lin Wan et al.
PROTEIN EXPRESSION AND PURIFICATION (2006)
CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model
AJ van Vuuren et al.
JOURNAL OF IMMUNOLOGY (2006)
Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro:: implications for the assessment of lymphangiogenesis
K Schledzewski et al.
JOURNAL OF PATHOLOGY (2006)
Immunotoxins for targeted cancer therapy
Robert J. Kreitman
AAPS JOURNAL (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1
ML Peterson et al.
INFECTION AND IMMUNITY (2005)
Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas
G von Minckwitz et al.
BREAST CANCER RESEARCH (2005)
Macrophages play a dual role during pulmonary tuberculosis in mice
JC Leemans et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent
EC Lavelle et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2, macrophages subvert, immunity to (myco)bacteria
FAW Verreck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effects of tumor necrosis factor-α (TNFα) in epidermal keratinocytes revealed using global transcriptional profiling
T Banno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD)
KR Reddy
SEMINARS IN LIVER DISEASE (2004)
Pegaspargase: a review of clinical studies
ML Graham
ADVANCED DRUG DELIVERY REVIEWS (2003)
Regulation of chemokine expression by antiinflammatory cytokines
TA Hamilton et al.
IMMUNOLOGIC RESEARCH (2002)
Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins:: A new strategy in the treatment of chronic inflammatory diseases and HIV
H Brühl et al.
JOURNAL OF IMMUNOLOGY (2001)
Growth regulation of skin fibroblasts
K Takehara
JOURNAL OF DERMATOLOGICAL SCIENCE (2000)
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins
A Bolognesi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity
Y Tsutsumi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Resolution of cutaneous inflammation after local elimination of macrophages
T Thepen et al.
NATURE BIOTECHNOLOGY (2000)
Share Paper
